AR047819A1 - Un anticuerpo monoclonal anti-tenascina humana - Google Patents
Un anticuerpo monoclonal anti-tenascina humanaInfo
- Publication number
- AR047819A1 AR047819A1 ARP050100671A ARP050100671A AR047819A1 AR 047819 A1 AR047819 A1 AR 047819A1 AR P050100671 A ARP050100671 A AR P050100671A AR P050100671 A ARP050100671 A AR P050100671A AR 047819 A1 AR047819 A1 AR 047819A1
- Authority
- AR
- Argentina
- Prior art keywords
- monoclonal antibody
- human anti
- tenascine
- tenascin
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Anticuerpo monoclonal anti-tenascina humana cuya secuencias de region variable de cadena liviana y de cadena pesada son SEQ ID 1 y SEQ ID 2, respectivamente, sus fragmentos proteolíticos capaces de ligarse a un epitopo antigénico dentro de la region A(1-4)-D de la tenascina humana, sus derivados recombinantes, sus conjugados y sus análogos funcionales similares capaces de ligarse a un epitopo antigénico dentro de la region A(1-4)-D de la tenascina humana.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000105A ITRM20040105A1 (it) | 2004-02-27 | 2004-02-27 | Anticorpo monoclonale antitenascina umana. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR047819A1 true AR047819A1 (es) | 2006-02-22 |
Family
ID=34897820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050100671A AR047819A1 (es) | 2004-02-27 | 2005-02-24 | Un anticuerpo monoclonal anti-tenascina humana |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7989171B2 (es) |
| EP (1) | EP1718678B1 (es) |
| JP (1) | JP5191036B2 (es) |
| KR (1) | KR101266389B1 (es) |
| CN (1) | CN1946740B (es) |
| AR (1) | AR047819A1 (es) |
| AU (1) | AU2005217237B2 (es) |
| BR (1) | BRPI0508082A8 (es) |
| CA (1) | CA2558718C (es) |
| ES (1) | ES2654065T3 (es) |
| HK (1) | HK1100848A1 (es) |
| IT (1) | ITRM20040105A1 (es) |
| MX (1) | MXPA06009674A (es) |
| PL (1) | PL1718678T3 (es) |
| PT (1) | PT1718678T (es) |
| WO (1) | WO2005082938A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006213607A1 (en) | 2005-02-11 | 2006-08-17 | Amylin Pharmaceuticals, Llc | GIP analog and hybrid polypeptides with selectable properties |
| US8263545B2 (en) | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
| JP2012031084A (ja) * | 2010-07-29 | 2012-02-16 | Tokyo Univ Of Science | 抗腫瘍剤 |
| WO2014113459A1 (en) * | 2013-01-15 | 2014-07-24 | Duke University | Hiv-1 neutralizing factor |
| US20160097771A1 (en) * | 2013-05-21 | 2016-04-07 | NX Pharmagen | Use of tenascin-c as an extracellular marker of tumor-derived microparticles |
| GB201616596D0 (en) * | 2016-09-29 | 2016-11-16 | Nascient Limited | Epitope and antibodies |
| WO2023240135A2 (en) | 2022-06-07 | 2023-12-14 | Actinium Pharmaceuticals, Inc. | Bifunctional chelators and conjugates |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5634076A (en) * | 1994-10-04 | 1997-05-27 | Analog Devices, Inc. | DMA controller responsive to transition of a request signal between first state and second state and maintaining of second state for controlling data transfer |
| US6014709A (en) * | 1997-11-05 | 2000-01-11 | Unisys Corporation | Message flow protocol for avoiding deadlocks |
| US6335014B1 (en) * | 1998-06-17 | 2002-01-01 | The Institute Of Physical And Chemical Research | Medicament for suppressing cancer metastasis |
| US6521593B1 (en) * | 1999-02-01 | 2003-02-18 | Childrens Hospital Los Angeles | Methods for inhibiting brain tumor growth |
| JP2003512300A (ja) * | 1999-05-01 | 2003-04-02 | ユニバーシティー オブ メディシン アンド デンティストリー オブ ニュー ジャージー | テネイシンｃによる軸索突起の伸長及び誘導 |
| US7058750B1 (en) * | 2000-05-10 | 2006-06-06 | Intel Corporation | Scalable distributed memory and I/O multiprocessor system |
| JP3646159B2 (ja) * | 2001-02-08 | 2005-05-11 | 国立大学法人三重大学 | 抗テネイシンｃモノクローナル抗体及び当該抗体を産生するハイブリドーマ |
| ITRM20010079A1 (it) * | 2001-02-16 | 2002-08-16 | Sigma Tau Ind Farmaceuti | Amminoderivati della biotina e loro coniugati con chelanti macrociclici. |
| ES2352180T3 (es) * | 2002-02-26 | 2011-02-16 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Anticuerpo monoclonal de anti-tenascina humana. |
| ITRM20020128A1 (it) * | 2002-03-08 | 2003-09-08 | Sigma Tau Ind Farmaceuti | Dimeri di avidina efficaci nell'incrementare la concentrazione di biotina radioattiva nella immunoterapia con "pretargeting". |
-
2004
- 2004-02-27 IT IT000105A patent/ITRM20040105A1/it unknown
-
2005
- 2005-02-16 WO PCT/IT2005/000078 patent/WO2005082938A2/en active Application Filing
- 2005-02-16 CN CN2005800061324A patent/CN1946740B/zh not_active Expired - Fee Related
- 2005-02-16 JP JP2007500356A patent/JP5191036B2/ja not_active Expired - Fee Related
- 2005-02-16 MX MXPA06009674A patent/MXPA06009674A/es active IP Right Grant
- 2005-02-16 US US10/590,936 patent/US7989171B2/en not_active Expired - Fee Related
- 2005-02-16 BR BRPI0508082A patent/BRPI0508082A8/pt not_active IP Right Cessation
- 2005-02-16 PT PT57189888T patent/PT1718678T/pt unknown
- 2005-02-16 ES ES05718988.8T patent/ES2654065T3/es active Active
- 2005-02-16 EP EP05718988.8A patent/EP1718678B1/en active Active
- 2005-02-16 AU AU2005217237A patent/AU2005217237B2/en not_active Ceased
- 2005-02-16 CA CA2558718A patent/CA2558718C/en not_active Expired - Fee Related
- 2005-02-16 PL PL05718988T patent/PL1718678T3/pl unknown
- 2005-02-24 AR ARP050100671A patent/AR047819A1/es not_active Application Discontinuation
-
2006
- 2006-09-27 KR KR1020067020062A patent/KR101266389B1/ko active IP Right Grant
-
2007
- 2007-08-06 HK HK07108522.3A patent/HK1100848A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL1718678T3 (pl) | 2018-05-30 |
| WO2005082938A2 (en) | 2005-09-09 |
| US7989171B2 (en) | 2011-08-02 |
| EP1718678A2 (en) | 2006-11-08 |
| CA2558718A1 (en) | 2005-09-09 |
| KR101266389B1 (ko) | 2013-05-28 |
| MXPA06009674A (es) | 2007-03-21 |
| CA2558718C (en) | 2015-01-13 |
| ES2654065T3 (es) | 2018-02-12 |
| CN1946740B (zh) | 2012-09-05 |
| WO2005082938A3 (en) | 2005-12-15 |
| AU2005217237A1 (en) | 2005-09-09 |
| JP5191036B2 (ja) | 2013-04-24 |
| JP2008506355A (ja) | 2008-03-06 |
| BRPI0508082A8 (pt) | 2017-12-26 |
| EP1718678B1 (en) | 2017-10-11 |
| HK1100848A1 (en) | 2007-09-28 |
| PT1718678T (pt) | 2017-12-29 |
| US20100297003A1 (en) | 2010-11-25 |
| CN1946740A (zh) | 2007-04-11 |
| BRPI0508082A (pt) | 2007-07-17 |
| AU2005217237B2 (en) | 2011-12-22 |
| KR20070002029A (ko) | 2007-01-04 |
| ITRM20040105A1 (it) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS54046B1 (en) | ANTI-MIOSTATIN ANTITELA | |
| CY1112993T1 (el) | Παραγοντες ειδικης δεσμευσης της αγγειοποιητινης-2 και της αγγειοποιητινης-1 | |
| ECSP077310A (es) | Anticuerpos anti-5t4 humanizados y conjugados de anticuerpos anti-5t4/caliqueamicina | |
| GT200600065A (es) | Anticuerpos para interleucina-17f y otros antagonistas de la señalizacion de il-17f y sus usos | |
| CY1106594T1 (el) | Αντισωματα εναντι ανθρωπινης il-12 | |
| PE20150222A1 (es) | Anticuerpos multiespecificos | |
| PE20130643A1 (es) | Conjugados de anticuerpos multifuncionales | |
| CR20130351A (es) | Anticuerpos monoclonales humanos para la quinasa-1 tipo receptor de activina (diviisional 9819) | |
| MX2009002711A (es) | Anticuerpos anti-receptor de folato alfa humanos y fragmentos de anticuerpo para la radioinmunoterapia de carcinoma de ovario. | |
| ES2694564T3 (es) | Polipéptidos de interleucina-2 mutantes | |
| PE20121616A1 (es) | Anticuerpos anti-her3 | |
| AR038700A1 (es) | Anticuerpos monoclonales anti-tenascina humana | |
| CY1116913T1 (el) | Τροποποιημενα κλασματα fab αντισωματων | |
| EA200701911A1 (ru) | Химерные рекомбинантные антигены toxoplasma gondii | |
| RS54468B1 (en) | MONOCLONAL ANTIBODIES AGAINST CLAUDINE-18 FOR THE CANCER TREATMENT | |
| DK1625209T3 (da) | Kimære immunoglobulin-monomer-dimer-hybrider | |
| PE20080119A1 (es) | Anticuerpos anti-5ta y sus usos | |
| PE20110668A1 (es) | Anticuerpos anti-linfopoyetina estromal timica (anti-tslp) | |
| RS54111B1 (en) | ANTI-ALPHA 2 INTEGRIN ANTIBODIES AND THEIR USES | |
| PE20120427A1 (es) | Anticuerpos contra el receptor de cgrp humano | |
| PE20061329A1 (es) | Anticuerpos ab humanizados para mejorar la cognicion | |
| DE602004023476D1 (de) | Dimerisiertes peptid | |
| EP1519747A4 (en) | HUMAN MONOCLONAL ANTIBODIES AGAINST PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) | |
| RS52782B (en) | HIGH AFINITY HUMAN ANTIBODIES FOR THE HUMAN IL-4 RECEPTOR | |
| EA201070888A1 (ru) | Антитела и их производные |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |